Recent Advances in the Therapy of Castration-Resistant Prostate Cancer: The Price of Progress

Maturitas - Ireland
doi 10.1016/j.maturitas.2011.07.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Recent Advances on the Progressive Mechanism and Therapy in Castration-Resistant Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

The Treatment Patterns of Castration Resistant Prostate Cancer in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

Metastatic Castration-Resistant Prostate Cancer: The Emerging Continuum of Care

Journal of the Canadian Urological Association
OncologyUrology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy